FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Efficacy and Safety of IRR Combo in Untreated FL and MZL May 30, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Evaluating Imaging for Indolent Cutaneous B-cell Lymphomas May 24, 2024
Lymphoma,MZL (Marginal Zone Lymphoma) IRTA1 Positivity in PCMZL: Implications Beyond IgM Expression Apr 10, 2024
Lymphoma,MZL (Marginal Zone Lymphoma) Parsaclisib Monotherapy Shows Promising Results in R/R MZL Feb 29, 2024
Lymphoma,MZL (Marginal Zone Lymphoma) [68Ga]Ga- Pentixa For Outperforms [18F]FDG PET in MZL Diagnosis Feb 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Subcutaneous Epcoritamab Is Well-Tolerated And Effective In Patients With R/R LBCL Oct 05, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Epcoritamab Shows Lasting Remissions in R/R LBCL Patients Oct 04, 2023